Milestone Pharmaceuticals (MIST)
(Delayed Data from NSDQ)
$1.54 USD
-0.04 (-2.53%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $1.54 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.26 | 0.00% |
Earnings Summary
For their last quarter, Milestone Pharmaceuticals (MIST) reported earnings of -$0.32 per share, missing the Zacks Consensus Estimate of -$0.30 per share. This reflects a negative earnings surprise of 6.67%. Look out for MIST's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.26 per share, reflecting a year-over-year increase of 25.71%.
Earnings History
Price & Consensus
Zacks News for MIST
Milestone Pharma (MIST) Down on Regulatory Update for Etripamil
MIST: What are Zacks experts saying now?
Zacks Private Portfolio Services